Low-Dose Naltrexone in Diseases' Treatment: Global Review

Corrigendum: The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study 

J Crohns Colitis
09 September 2019
https://academic.oup.com/ecco-jcc/advance-article/doi/10.1093/ecco-jcc/jjz101/5566443

Use of low dose naltrexone and change in use of prescription drugs in patients with inflammatory bowel disease – A drug utilization cohort study based on the Norwegian prescription register

Research in Social and Administrative Pharmacy
May–June 2017
https://www.sciencedirect.com/science/article/abs/pii/S1551741117302152

Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders

Int J Pharm Compd
Mar-Apr 2010
https://mail.google.com/mail/u/0?ui=2&ik=b5d7923c33&attid=0.2&permmsgid=msg-f:1668161843235939361&th=1726805badf06421&view=att&disp=safe

Low Dose Naltrexone Reduces In Vitro Endoplasmic Reticulum Stress and Stimulates Wound Healing in Intestinal Epithelial Cells

Journal of Crohn's and Colitis
March 2016
https://academic.oup.com/ecco-jcc/article/10/suppl_1/S136/2481649

The opioid antagonist naltrexone improves murine inflammatory bowel disease

J Immunotoxicol
April 2008
https://pubmed.ncbi.nlm.nih.gov/18569389/

Leonard Weinstock, MD - Celiac Disease (2017 Conference) (LDN, low dose naltrexone)

Celiac disease is a remarkable condition. It can present in so many different ways and have so many symptoms. What we're going to try is to hone down on the autoimmune conditions that are associated with it, which don't get as much attention in the literature as they should.

Nasha Winters, ND - Navigating the Narrative (2017 Conference) (LDN, low dose naltrexone)

Dr Nasha Winters speaks from experience when she talks about Cancer and how to be proactive in preventing and/or combating it. In her youth she was diagnosed with a terminal Cancer, but discovered the life changes that would turn it around. 

Leonard Weinstock, MD - Inflammatory Bowel Disease II (2017 Conference) (LDN, low dose naltrexone)

Inflammatory bowel disease is a condition that we see as gastroenterologists on a daily basis. I'm Dr. Weinstock. I'd like to review inflammatory bowel disease, what the traditional approaches are, and some of the newer changes that we've seen with low dose naltrexone. Here are my disclosures.